Next Article in Journal
The Diagnostic Differences of Asthma in the Elderly
Previous Article in Journal
Isolated Sarcoidosis of Upper Respiratory Tract—A Description of 2 Cases
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Pulmonary Epithelioid Haemangioendothelioma—Interferon 2-Alpha Treatment—Case Report

by
Elżbieta Radzikowska
*,
Ewa Szczepulska-Wójcik
,
Mariusz Chabowski
,
Karina Oniszh
,
Renata Langfort
and
Kazimierz Roszkowski
National Tuberculosis and Lung Diseases Research Institute, Plocka Street 26, 01-138 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2008, 76(4), 281-285; https://doi.org/10.5603/ARM.27887
Submission received: 13 September 2007 / Revised: 22 June 2008 / Accepted: 22 June 2008 / Published: 22 June 2008

Abstract

A 62-year-old, obese woman, smoking 10 pack/year was admitted to the National Tuberculosis and Lung Diseases Research Institute to diagnose small, round opacities revealed by routine chest X-ray examination. These lesions had been observed for 5 years. The patient had been treated for psoriasis, hypertension, and insulin-independent diabetes. On admission she was in good condition, complaining of a slight productive cough as well as intermittent osteoarticular pain. Physical examination revealed cutaneous psoriatic lesions, slight edema of the lower limbs, and clubbed fingers. Tuberculin test was positive. Chest Computer Tomography scanning showed partially calcified nodules (up to 1cm in diameter) located in the middle and base areas of both lungs. No evidence of hilar nor mediastinal lymph node enlargement was seen. Lung specimens displayed intraalveolar and intravascular growth of neoplastic cells. Immunohistochemical expression of Factor VIII, CD31 and CD34 antigens was present. Pulmonary epithelioid haemangioendothelioma was diagnosed. After 6 months of observation, progression of the disease was shown. Interferon alpha treatment was introduced. During the therapy, a slight regression of pulmonary changes was noticed and since then stabilization of the disease was observed.
Keywords: pulmonary epithelioid haemangioendothelioma; lung; interferon 2-alpha pulmonary epithelioid haemangioendothelioma; lung; interferon 2-alpha

Share and Cite

MDPI and ACS Style

Radzikowska, E.; Szczepulska-Wójcik, E.; Chabowski, M.; Oniszh, K.; Langfort, R.; Roszkowski, K. Pulmonary Epithelioid Haemangioendothelioma—Interferon 2-Alpha Treatment—Case Report. Adv. Respir. Med. 2008, 76, 281-285. https://doi.org/10.5603/ARM.27887

AMA Style

Radzikowska E, Szczepulska-Wójcik E, Chabowski M, Oniszh K, Langfort R, Roszkowski K. Pulmonary Epithelioid Haemangioendothelioma—Interferon 2-Alpha Treatment—Case Report. Advances in Respiratory Medicine. 2008; 76(4):281-285. https://doi.org/10.5603/ARM.27887

Chicago/Turabian Style

Radzikowska, Elżbieta, Ewa Szczepulska-Wójcik, Mariusz Chabowski, Karina Oniszh, Renata Langfort, and Kazimierz Roszkowski. 2008. "Pulmonary Epithelioid Haemangioendothelioma—Interferon 2-Alpha Treatment—Case Report" Advances in Respiratory Medicine 76, no. 4: 281-285. https://doi.org/10.5603/ARM.27887

Article Metrics

Back to TopTop